Remember the dates
26 MAY 2020
MDR fully applies; Certificates issued under the MDD before the MDR fully applies may remain valid for up to 4 additional years
26 MAY 2024
All devices placed on the market must be in conformity with the MDR
要查看或添加评论，请登录
Robert Heinz Günter的更多文章
-
Einladung Webinar: Ultrarapid RNA-based Gene fusion detection in under 3 hours - ALK, ROS1, RET, NTRK1/2/3 Rearrangements and MET Exon 14 Skipping2022年6月21日
Einladung Webinar: Ultrarapid RNA-based Gene fusion detection in under 3 hours - ALK, ROS1, RET, NTRK1/2/3 Rearrangements and MET Exon 14 Skipping
Register via Registration (gotowebinar.com) When: Wed, Jun 29, 2022 7:00 PM - 7:45 PM CEST Presenter: Maria E.
16
-
New Study Led by Memorial Sloan Kettering Cancer Center (NY, US) Shows Idylla? GeneFusion Assay Enables More Rapid Screening of Targetable Fusions Com2022年5月5日
New Study Led by Memorial Sloan Kettering Cancer Center (NY, US) Shows Idylla? GeneFusion Assay Enables More Rapid Screening of Targetable Fusions Com
Therapeutically actionable gene fusions drive approximately 10% of non-small-cell lung cancers1 Current molecular…
20
1 条评论 -
One more for Idylla: Biocartis and Ophiomics collaborates on liver cancer test to identify which patients will benefit from liver transplantation2022年2月10日
One more for Idylla: Biocartis and Ophiomics collaborates on liver cancer test to identify which patients will benefit from liver transplantation
Press Release 8th Feb 2022 ? Primary liver cancer is the sixth most common and third most lethal cancer in the world ?…
10
-
8th Emirates Pathology & Digital Pathology2021年8月2日
8th Emirates Pathology & Digital Pathology
Participate at 8th Emirates Pathology / Digital Pathology and join my talk about "From Sample to MDx result in less…
3
-
Zwei (weitere) Gründe warum Fast Track Analysen in der Molekularpathologie für Krebspatienten notwendig sind2021年7月28日
Zwei (weitere) Gründe warum Fast Track Analysen in der Molekularpathologie für Krebspatienten notwendig sind
Welche Auswirkungen kann eine l?ngere Wartezeit auf den Therapiebeginn für Patienten haben? Nach Song et al. 2017…
-
New data on SeptiCyte? RAPID’s ability to differentiate severe/critical from mild/moderate COVID-19 patients close to hospital admission2021年7月26日
New data on SeptiCyte? RAPID’s ability to differentiate severe/critical from mild/moderate COVID-19 patients close to hospital admission
We are pleased to share with you our most recent data on SeptiCyte? RAPID performance in COVID-19 patients, which was…
1
-
Good pharmacovigilance practices update released for public consultation until 28th Feb 20202019年12月11日
Good pharmacovigilance practices update released for public consultation until 28th Feb 2020
Today, the Considerations Chapter P.III focussing on pharmacovigilance for the use of medicines by pregnant and…
社区洞察
-
Industrial DesignHow can you design a GMP process that adapts to changing customer needs?
-
Manufacturing OperationsHow can you help your team understand the importance of GMP in quality culture?
-
GMPHow do you report GMP packaging and labeling errors?
-
GMPHow can you get the most from third-party GMP inspections?
-
GMPHow do you handle GMP quality complaints?
-
Call Center AdministrationWhat does a regulatory associate do?
-
Contract NegotiationHow can you negotiate contracts in the health care and pharmaceutical industries?
-
Quality ManagementHow can you prioritize and categorize deviations in your GMP process?
-
GMPHow can you overcome challenges with eQMS in GMP?
-
Quality ManagementWhat are the most effective ways to overcome GMP challenges?
其他会员也浏览了
-
Raising the Standards Bar Across the Board with EU MDR 2017/745 and IVDR 2017/746: The Regulatory Stakeholders Should Do More
Gabriel Opoku Adusei, MSc, PhD 5 年 -
EU MDR and UKCA on scope
Monir El Azzouzi 1 年 -
MDR extended transition period and notified body agreement
mdi Europa GmbH 5 个月 -
10 THINGS YOU NEED TO KNOW BEFORE THE MDR: European Authorised Representative
Katarzyna Weso?owska 4 年 -
MDR Ge?i? Sürecinin 2 ?nemli Tarihi/2 Important Dates of the MDR Transition Process
CENK KILIC KALKAN 2 年 -
Biocompatibility of Medical Devices – Responsibilities of the Supply Chain
Chorley Consulting Ltd 1 年 -
EU Classifications and Rules for CE Marking
Parul Chansoria 2 年 -
EU MDR Date Of Application Is Approaching: Should You Certify?
Ethan Drower 5 年 -
Brexit and the CE Mark - implications for European regulation of medical devices
Arthur Brandwood 8 年 -
Is MDR Uncertainty Undermining NHS Net Zero Progress?
Tautvydas Karitonas 2 年